MedPath
NMPA Approval

Serplulimab Injection

国药准字S20220013

March 22, 2022

Drug Information

斯鲁利单抗注射液

汉斯状

注射剂

100mg(10ml)/瓶

生物制品

March 22, 2022

Company Information

Applicant Company

上海市徐汇区宜山路1289号1幢(D楼)全幢

Manufacturing Company

上海市徐汇区宜山路1289号1幢(D楼)全幢

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

斯鲁利单抗注射液 - NMPA 批准文号 | MedPath